{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:35:40Z","timestamp":1790645740604,"version":"4.1.0"},"reference-count":22,"publisher":"American Society for Microbiology","issue":"8","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"HHS | National Institutes of Health","doi-asserted-by":"publisher","award":["P30 CA21765"],"award-info":[{"award-number":["P30 CA21765"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2018,8]]},"abstract":"<jats:p>\n            <jats:named-content content-type=\"genus-species\">Pneumocystis jirovecii<\/jats:named-content>\n            pneumonia is a life-threatening opportunistic infection in children receiving immunosuppressive chemotherapy. Without prophylaxis, up to 25% of pediatric oncology patients receiving chemotherapy will develop\n            <jats:named-content content-type=\"genus-species\">Pneumocystis jirovecii<\/jats:named-content>\n            pneumonia.\n          <\/jats:p>","DOI":"10.1128\/aac.00173-18","type":"journal-article","created":{"date-parts":[[2018,6,5]],"date-time":"2018-06-05T12:49:08Z","timestamp":1528202948000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":24,"title":["Pentamidine for Prophylaxis against Pneumocystis jirovecii Pneumonia in Pediatric Oncology Patients Receiving Immunosuppressive Chemotherapy"],"prefix":"10.1128","volume":"62","author":[{"given":"Melissa","family":"Quinn","sequence":"first","affiliation":[{"name":"Pharmaceutical Department, St. Jude Children's Research Hospital, Memphis, Tennessee, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. T.","family":"Fannin","sequence":"additional","affiliation":[{"name":"Pharmaceutical Department, St. Jude Children's Research Hospital, Memphis, Tennessee, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Sciasci","sequence":"additional","affiliation":[{"name":"Pharmaceutical Department, St. Jude Children's Research Hospital, Memphis, Tennessee, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Bragg","sequence":"additional","affiliation":[{"name":"Pharmaceutical Department, St. Jude Children's Research Hospital, Memphis, Tennessee, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick K.","family":"Campbell","sequence":"additional","affiliation":[{"name":"Department of Oncology, Leukemia\/Lymphoma Division, St. Jude Children's Research Hospital, Memphis, Tennessee, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delia","family":"Carias","sequence":"additional","affiliation":[{"name":"Pharmaceutical Department, St. Jude Children's Research Hospital, Memphis, Tennessee, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine R.","family":"Crews","sequence":"additional","affiliation":[{"name":"Pharmaceutical Department, St. Jude Children's Research Hospital, Memphis, Tennessee, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Gregornik","sequence":"additional","affiliation":[{"name":"Pharmaceutical Department, St. Jude Children's Research Hospital, Memphis, Tennessee, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sima","family":"Jeha","sequence":"additional","affiliation":[{"name":"Department of Oncology, Leukemia\/Lymphoma Division, St. Jude Children's Research Hospital, Memphis, Tennessee, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Maron","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Pauley","sequence":"additional","affiliation":[{"name":"Pharmaceutical Department, St. Jude Children's Research Hospital, Memphis, Tennessee, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hope D.","family":"Swanson","sequence":"additional","affiliation":[{"name":"Pharmaceutical Department, St. Jude Children's Research Hospital, Memphis, Tennessee, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Wolf","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Greene","sequence":"additional","affiliation":[{"name":"Pharmaceutical Department, St. Jude Children's Research Hospital, Memphis, Tennessee, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197712292972602"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.1157"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-73-5-695"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(73)80113-1"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.4065\/82.9.1052"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1994.12.1.136"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1994.12.2.258"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02290-15"},{"key":"e_1_3_3_10_2","unstructured":"National Institute for Occupational Safety and Health. 2014. NIOSH list of antineoplastic and other hazardous drugs in healthcare settings 2014. U.S. Department of Health and Human Services CfDCaP National Institute for Occupational Safety and Health Cincinnati OH. https:\/\/www.cdc.gov\/niosh\/docs\/2014-138\/pdfs\/2014-138_v3.pdf."},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21287"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2016.0093"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/18.6.901"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/24.5.854"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/petr.12441"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26453"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-112-10-750"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e318292f560"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2016.133"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000000946"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0000000000000584"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0000000000000644"},{"key":"e_1_3_3_23_2","volume-title":"S","author":"National Cancer Institute","year":"2009","unstructured":"National Cancer Institute. 2009. Common Terminology Criteria for Adverse Events (CTCAE) v4.0, publication 09-7473. National Cancer Institute, NIH, U. S. Department of Health and Human Services, Rockville, MD."}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00173-18","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00173-18","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T21:20:50Z","timestamp":1645478450000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.00173-18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":22,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["10.1128\/AAC.00173-18"],"URL":"https:\/\/doi.org\/10.1128\/aac.00173-18","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"2018-01-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-05-30","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-07-27","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00173-18"}}